FDA Draft Guidance for Industry on Establishing Sanitation Programs for Low-Moisture Ready-to-Eat Human Foods Webinar
This webinar was presented by Maile Gradison, ASTA's General Counsel and partner at Hogan Lovells, and Anneke Altieri, Senior Associate with Hogan Lovells. The presentation will review FDA draft guidance published on January 6, 2025, intended to help manufacturers of Low-Moisture Ready-to-Eat (LMRTE) human foods, such as spices, establish sanitation programs and take appropriate corrective actions following a pathogen contamination event.
Membership Required
A valid ASTA membership is required to access this page. Please use the form below to log in with your ASTA member account.
Log in
Not a member yet? Click here to learn about joining ASTA today.
Related Resources
ASTA Webinar on How to Develop an FSMA-Ready Environmental Monitoring Program
ASTA's Clean, Safe Spices Guidance recommends that allspice companies develop and implement an environmental monitoring program. FSMA has underscored the need to do so. The series features Dr. James Dickson and attorney Maile Hermida for a 90-minute webinar to learn how to develop an FSMA-ready program and understand the related legal issues. Dr. Dickson provides details on what the key elements of a comprehensive environmental monitoring program are and gives advice on how to develop a program that is tailored to a spice facility. Ms. Hermida provides insight in FSMA requirements and FDA’s expectations for RTE foods, as well as the legal liability’s companies face related to environmental monitoring.
ASTA Ready-to-Eat FAQs
The microbial safety of “ready-to-eat” (RTE) foods is a hot topic that ASTA is hearing a lot about when it comes to implementation of the Food Safety Modernization Act (FSMA). The U.S. Food and Drug Administration (FDA) has not yet published guidance regarding classifying and processing RTE foods. In these “frequently asked questions” (FAQs), ASTA is sharing information on positions FDA could take on RTE based on the preambles to the FSMA final rules, talks that FDA officials have given, information published in the update to the spice draft risk profile, informal conversations with FDA officials, and other published FDA draft guidance. ASTA has produced these FAQs in order to help members understand FDA’s current thinking on RTE foods, but we note that we have not received input on this document from FDA.